Cover Image

Serum glucagon, bile acids, and FGF-19: metabolic behavior patterns after Roux-en-Y gastric bypass and vertical sleeve gastrectomy

Metabolic/bariatric surgery is a highly effective treatment for obesity and metabolic diseases. Serum glucagon, bile acids, and FGF-19 are key effectors of various metabolic processes and may play central roles in bariatric surgical outcomes. It is unclear whether these factors behave similarly afte...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang, Cui (Author) , Brecht, Julia (Author) , Weiß, Christel (Author) , Reißfelder, Christoph (Author) , Otto, Mirko (Author) , Buchwald, Jane N. (Author) , Vassilev, Georgi (Author)
Format: Article (Journal)
Language:English
Published: November 2021
In: Obesity surgery
Year: 2021, Volume: 31, Issue: 11, Pages: 4939-4946
ISSN:1708-0428
DOI:10.1007/s11695-021-05677-3
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11695-021-05677-3
Get full text
Author Notes:Cui Yang, Julia Brecht, Christel Weiß, Christoph Reissfelder, Mirko Otto, Jane N. Buchwald, Georgi Vassilev
Description
Summary:Metabolic/bariatric surgery is a highly effective treatment for obesity and metabolic diseases. Serum glucagon, bile acids, and FGF-19 are key effectors of various metabolic processes and may play central roles in bariatric surgical outcomes. It is unclear whether these factors behave similarly after Roux-en-Y gastric bypass (RYGB) vs vertical sleeve gastrectomy (VSG).
Item Description:Published online: 30 August 2021
Gesehen am 02.06.2023
Physical Description:Online Resource
ISSN:1708-0428
DOI:10.1007/s11695-021-05677-3

Similar Items